Hugel, a leading global medical aesthetics company, announced record-breaking net sales and operating profit for the third quarter of 2024. The company’s strong performance was driven by its global expansion, particularly the initial shipment of its botulinum toxin product to the US market. Hugel is poised for further growth, with plans to expand its presence in the US and other key markets.
U.S. health officials have alerted doctors, healthcare providers, and the public about counterfeit Botox injections that have affected numerous individuals across 11 states since November 2023. The injections, administered by unlicensed or untrained people, have resulted in hospitalizations and suspected botulism cases. Individuals are advised to only receive Botox injections from licensed professionals and report any suspected counterfeit products or adverse reactions.
